Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

Joseph Treat,René Gonin,Martin J. Edelman,Chandra P. Belani,Mark A. Socinski,Robert B. Catalano,Donna M. Marinucci,Rafat Ansari,Robert L. Comis,Coleman K. Obasaju

Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

2007

Joseph Treat
René Gonin
Martin J. Edelman
Chandra P. Belani
Mark A. Socinski
Robert B. Catalano
Donna M. Marinucci
Rafat Ansari
Robert L. Comis
Coleman K. Obasaju

18066 Background: A relationship between race and prognosis in patients with NSCLC has been suggested with African Americans (AA) having higher incidence and lower survival rates compared to whites...

Keywords:

Carboplatin
non-small cell lung cancer (NSCLC)
Paclitaxel
Gemcitabine
Subgroup analysis
Internal medicine
Oncology
Cancer research
Medicine
advanced stage
african american

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations